Global Pharmacogenomics Technology (Theranostics & CDx) Market Growth (Status and Outlook) 2023-2029

Global Pharmacogenomics Technology (Theranostics & CDx) Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Pharmacogenomics Technology (Theranostics & CDx) Industry Forecast” looks at past sales and reviews total world Pharmacogenomics Technology (Theranostics & CDx) sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmacogenomics Technology (Theranostics & CDx) sales for 2023 through 2029. With Pharmacogenomics Technology (Theranostics & CDx) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmacogenomics Technology (Theranostics & CDx) industry.
This Insight Report provides a comprehensive analysis of the global Pharmacogenomics Technology (Theranostics & CDx) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmacogenomics Technology (Theranostics & CDx) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmacogenomics Technology (Theranostics & CDx) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmacogenomics Technology (Theranostics & CDx) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmacogenomics Technology (Theranostics & CDx).
The global Pharmacogenomics Technology (Theranostics & CDx) market size is projected to grow from US$ 9383.3 million in 2022 to US$ 25340 million in 2029; it is expected to grow at a CAGR of 15.2% from 2023 to 2029.
Pharmacogenomics Technology (Theranostics & CDx) manufacturers include Illumina, Roche and Agilent etc. The top 3 company holds a share of more than 50%. North America takes up the largest sales market, with a share of more than 40%, followed by Europe and China, with the share of about 30% and 10% respectively.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmacogenomics Technology (Theranostics & CDx) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Instrument
Reagents and Consumables
Others
Segmentation by application
Tumor
Diabetes
Mental Diseases
Cardiovascular Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Roche
Agilent
Abbott
Thermofisher
Qiagen
Guardant Health
MGI Tech Co., Ltd.
Amoydx Biology
Genomics

Please note: The report will take approximately 2 business days to prepare and deliver.